£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Hormone Therapy for Prostate Cancer Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 07 August 2026 11 August 2026 15 August 2026 20 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £490 Days at Price

Price Analysis

Most common price: £490 (18 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 18 days

Description

This comprehensive study provides a detailed outlook for hormone therapy for prostate cancer therapeutics from 2023 to 2028. It focuses on latent demand across the United States, offering potential industry earnings (P.I.E.) estimates for 10,833 specific zip codes. By analyzing data at the zip code level, the report allows users to see the percent share each area holds relative to its state and the nation as a whole. These comparative benchmarks help professionals gauge specific locations against broader trends. This statistical approach serves as a tool for distribution and sales planning by identifying high-potential areas for prostate cancer therapeutics.

Key Features

Provides latent demand estimates in millions of U.S. dollars for hormone therapy therapeutics across the United States.

Includes detailed potential industry earnings (P.I.E.) estimates for 10,833 individual US zip codes.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the entire country.

Supports distribution and sales strategies through localized statistical data for prostate cancer treatments.

Covers a specific forecasting period from 2023 through 2028 for the US market.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
99% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 31 Oct 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
99% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

£515.00 15 Aug 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 20 Aug 2026
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
98% match

The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics

Price unavailable
Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
97% match

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Hormone Replacement Therapy Outlook 2023-2028 US Zip Codes
97% match

Hormone Replacement Therapy Outlook 2023-2028 US Zip Codes

£490.00 23 Aug 2026
Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028
97% match

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028

£490.00 24 Aug 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 23 Sep 2026
The 2025-2030 World Outlook for Prostate Cancer Treatments
96% match

The 2025-2030 World Outlook for Prostate Cancer Treatments

Price unavailable
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
96% match

The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

Price unavailable
Testosterone Replacement Therapy Outlook 2023-2028 Report
96% match

Testosterone Replacement Therapy Outlook 2023-2028 Report

£490.00 21 Aug 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 20 Aug 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

£520.00 28 Oct 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in China
96% match

The 2023-2028 Outlook for Hormone Replacement Therapies in China

£495.00 31 Oct 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India

£515.00 30 Oct 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in Japan
96% match

The 2023-2028 Outlook for Hormone Replacement Therapies in Japan

£495.00 15 Aug 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in India
96% match

The 2023-2028 Outlook for Hormone Replacement Therapies in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

£495.00 29 Oct 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in the United States
96% match

The 2023-2028 Outlook for Hormone Replacement Therapies in the United States

£520.00 01 Nov 2026
2013-2018 HRT Outlook Asia & Oceania - Market Analysis
95% match

2013-2018 HRT Outlook Asia & Oceania - Market Analysis

£325.00 08 Sep 2026
Hormone Replacement Therapy Outlook in Europe 2013-2018
95% match

Hormone Replacement Therapy Outlook in Europe 2013-2018

£325.00 15 Aug 2026
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Greater China
95% match

The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Greater China

£495.00 20 Aug 2026
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in India
95% match

The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in India

£495.00 15 Aug 2026